Biological warfare defense vaccine research and development program: hearing before the Subcommitttee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, October 23, 2001, Volumen4U.S. Government Printing Office, 2002 - 129 páginas |
Otras ediciones - Ver todas
Términos y frases comunes
American anthrax vaccine antibiotics antigen AVANT biodefense biological defense biological warfare BioPort biotechnology industry bioterrorism biowarfare C.L. BUTCH Chairman Christopher Shays Cipro clinical trials committee companies Congressman defense vaccines Department of Defense Development House Government disease doses drugs effective efficacy EluSys FAUCI FDA approved filter changes going Government Reform Subcommittee HHS Readiness House Government Reform human immune issue KINGSBURY KUCINICH LANTOS licensed manufacturing practices Michigan facility million National Security October October 23 panel pathogens Phase potential protective antigen public health system PUTNAM question Readiness and Role require Research and Development response Role in Vaccine RYAN safety SANDERS Secretary THOMPSON Security October 23 September 11th SHAYS smallpox vaccine stockpile studies Subcommittee on National SUDOVAR talked terrorist testimony testing Thank therapeutics there's things TIERNEY toxin tularemia USAMRIID vaccine production Vaccine Research WELDON WINEGER